Overjet, the world leader in dental AI, has just completed a $53.2 million Series C round. This is the largest-ever investment in artificial intelligence for dentistry. The deal brings Overjet's total funding to around $133 million, and the company's valuation to $550 million.
This new funding will enable the company to fuel its core mission: to make dentistry patient-centric, by providing dental professionals with the AI tools they need, in order to operate efficiently and give patients exceptional care.
This fund-raising follows a period of rapid growth in Overjet's activities, which will enable it to continue developing its market-leading AI, and eliminate discrepancies and uncertainties for patients at every stage. Ultimately, it will establish the first unified standard, linking the entire dental care ecosystem, from providers to payers as well as dental schools.
The company now serves thousands of dentists, from private practices to North America's largest dental care organizations (DSOs). Overjet's impact has been recognized beyond the dental sector, including by Forbes AI 50, Fast Company's World's Most Innovative Companies and Built In's Best Places to Work.
Founded in 2018 its platform is the only technology cleared by the US Food and Drug Administration (FDA) to detect, contour and quantify cases of oral disease, with millimeter-level accuracy. Without these services, different experts often interpret the same dental X-ray differently, which can lead to a breakdown in communication between doctors, insurers and patients. Patients refuse around 50% of treatments recommended by dentists, both because they don't understand the diagnosis and because they're not sure their insurance will cover them.
"Overjet's AI is already a game changer from a clinical perspective," said Mark Sivers, DMD, Chief Clinical Officer at Aligned Dental Partners. "What really excites me is Overjet's ability to create a common language between providers and customers."
